Literature DB >> 16233938

Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry.

Andrew Lees1, Goutam Sen, Alberto LopezAcosta.   

Abstract

Applications of oxime chemistry are described for the efficient bioconjugation of proteins and polysaccharides for the preparation of conjugate vaccines. A number of approaches are described in this manuscript to functionalize proteins and polysaccharides with aminooxy (AO) groups and aldehydes which could then be covalently linked to each other via oxime formation, without the need for reduction. By using limiting numbers of active groups on each component, the extent of inter- and intramolecular crosslinking could be controlled. The approaches described are compatible and complementary to a number of chemistries currently used in conjugate vaccine synthesis. Oxime chemistry can be used to both simplify the synthesis of and increase yields of conjugate vaccines. Mice immunized with pneumococcal type 14 conjugates that were made using oxime chemistry mounted significant anti-polysaccharide immune responses. The primary immune response could be boosted, indicating that the polysaccharide conjugate had characteristics of a T cell dependent antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16233938     DOI: 10.1016/j.vaccine.2005.08.096

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Teresa Lagergård; Ariel Ginzberg; Jerry D King; Andrew Preston; Duncan J Maskell; Vince Pozsgay; Jerry M Keith; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

2.  Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.

Authors:  Raphael Simon; Sharon M Tennant; Jin Y Wang; Patrick J Schmidlein; Andrew Lees; Robert K Ernst; Marcela F Pasetti; James E Galen; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

3.  The Influence of β-Ammonium Substitution on the Reaction Kinetics of Aminooxy Condensations with Aldehydes and Ketones.

Authors:  Mumiye A Ogunwale; Ralph J Knipp; Clint N Evrard; Lee M Thompson; Michael H Nantz; Xiao-An Fu
Journal:  Chemphyschem       Date:  2019-03-05       Impact factor: 3.102

4.  Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Gil Ben-Menachem; Vince Pozsgay; John B Robbins; Rachel Schneerson
Journal:  Vaccine       Date:  2008-05-20       Impact factor: 3.641

5.  Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice.

Authors:  Vince Pozsgay; Joanna Kubler-Kielb; Rachel Schneerson; John B Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

6.  Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes.

Authors:  Tinashe B Ruwona; Ryan Mcbride; Rebecca Chappel; Steven R Head; Phillip Ordoukhanian; Dennis R Burton; Mansun Law
Journal:  J Immunol Methods       Date:  2013-11-19       Impact factor: 2.303

7.  Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptides.

Authors:  Fa Liu; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2007-12-07       Impact factor: 2.823

8.  Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.

Authors:  Rafael Prados-Rosales; Leandro Carreño; Tingting Cheng; Caroline Blanc; Brian Weinrick; Adel Malek; Todd L Lowary; Andres Baena; Maju Joe; Yu Bai; Rainer Kalscheuer; Ana Batista-Gonzalez; Noemi A Saavedra; Leticia Sampedro; Julen Tomás; Juan Anguita; Shang-Cheng Hung; Ashish Tripathi; Jiayong Xu; Aharona Glatman-Freedman; Williams R Jacobs; John Chan; Steven A Porcelli; Jacqueline M Achkar; Arturo Casadevall
Journal:  PLoS Pathog       Date:  2017-03-09       Impact factor: 6.823

9.  Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.

Authors:  Scott M Baliban; Mingjun Yang; Girish Ramachandran; Brittany Curtis; Surekha Shridhar; Rachel S Laufer; Jin Y Wang; John Van Druff; Ellen E Higginson; Nicolas Hegerle; Kristen M Varney; James E Galen; Sharon M Tennant; Andrew Lees; Alexander D MacKerell; Myron M Levine; Raphael Simon
Journal:  PLoS Negl Trop Dis       Date:  2017-04-07

10.  A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Authors:  Anthony E Gregory; Barbara M Judy; Omar Qazi; Carla A Blumentritt; Katherine A Brown; Andrew M Shaw; Alfredo G Torres; Richard W Titball
Journal:  Nanomedicine       Date:  2014-09-03       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.